Literature DB >> 3402456

Assembly of asparagine-linked oligosaccharides in baby hamster kidney cells treated with castanospermine, an inhibitor of processing glucosidases.

L Foddy1, R C Hughes.   

Abstract

We have shown previously that the processing of asparagine-linked oligosaccharides in baby hamster kidney (BHK) cells is blocked only partially by the glucosidase inhibitors, 1-deoxynojirimycin and N-methyl-1-deoxynojirimycin [Hughes, R. C., Foddy, L. & Bause, E. (1987) Biochem. J. 247, 537-544]. Similar results are now reported for castanospermine, another inhibitor of processing glucosidases, and a detailed study of oligosaccharide processing in the inhibited cells is reported. In steady-state conditions the major endo-H-released oligosaccharides contained glucose residues but non-glycosylated oligosaccharides, including Man9GlcNAc to Man5GlcNAc, were also present. To determine the processing sequences occurring in the presence of castanospermine, BHK cells were pulse-labelled for various times with [3H]mannose and the oligosaccharide intermediates, isolated by gel filtration and paper chromatography, characterized by acetolysis and sensitivity to jack bean alpha-mannosidase. The data show that Glc3Man9GlcNAc2 is transferred to protein and undergoes processing to produce Glc3Man8GlcNAc2 and Glc3Man7GlcNAc2 as major species as well as a smaller amount of Man9GlcNAc2. Glucosidase-processed intermediates, Glc1Man8GlcNAc2 and Glc1Man7GlcNAc2, were also obtained as well as a Man7GlcNAc2 species derived from Glc1Man7GlcNAc2 and different from the Man7GlcNAc2 isomer formed in the usual processing pathway. No evidence for the direct transfer of non-glucosylated oligosaccharides to proteins was obtained and we conclude that the continued assembly of complex-type glycans in castanospermine-inhibited BHK cells results from residual activity of processing glucosidases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3402456     DOI: 10.1111/j.1432-1033.1988.tb14196.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Diastereoselective nitrenium ion-mediated cyclofunctionalization: total synthesis of (+)-castanospermine.

Authors:  Edward G Bowen; Duncan J Wardrop
Journal:  Org Lett       Date:  2010-10-21       Impact factor: 6.005

2.  Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein.

Authors:  M L Poss; S L Quackenbush; J I Mullins; E A Hoover
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Authors:  P B Fischer; M Collin; G B Karlsson; W James; T D Butters; S J Davis; S Gordon; R A Dwek; F M Platt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

4.  Effects of brefeldin A on oligosaccharide processing. Evidence for decreased branching of complex-type glycans and increased formation of hybrid-type glycans.

Authors:  D Chawla; R C Hughes
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

5.  Effect of inhibiting N-glycosylation or oligosaccharide processing on vasoactive intestinal peptide receptor binding activity and structure.

Authors:  A el Battari; P Forget; F Fouchier; P Pic
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

6.  Spiro-epoxyglycosides as Activity-Based Probes for Glycoside Hydrolase Family 99 Endomannosidase/Endomannanase.

Authors:  Sybrin P Schröder; Wouter W Kallemeijn; Marjoke F Debets; Thomas Hansen; Lukasz F Sobala; Zalihe Hakki; Spencer J Williams; Thomas J M Beenakker; Johannes M F G Aerts; Gijsbert A van der Marel; Jeroen D C Codée; Gideon J Davies; Herman S Overkleeft
Journal:  Chemistry       Date:  2018-06-21       Impact factor: 5.236

7.  Impact of cell culture media additives on IgG glycosylation produced in Chinese hamster ovary cells.

Authors:  Janike Ehret; Martina Zimmermann; Thomas Eichhorn; Aline Zimmer
Journal:  Biotechnol Bioeng       Date:  2019-01-21       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.